Bone Marrow Transplantation Market 2018-2026 | Size, Share, Opportunities and Forecast | Credence Research

The global bone marrow transplantation market was valued at US$ 8,356.4 Mn in 2017, and is expected to reach US$ 13,903.1 Mn by 2026, expanding at a CAGR of 5.9% from 2018 to 2026.

The latest market report published by Credence Research, Inc. "Global Bone Marrow Transplantation Market -Growth, Future Prospects, Competitive Analysis, 2018 -2026," the global bone marrow transplantation market was valued at US$ 8,356.4 million in 2017 and is expected to reach US$ 13,903.1 million by 2026, expanding at a CAGR of 5.9% from 2018 to 2026.

Market Insights

Blood cancer is characterized by overproduction of an abnormal type of blood cells, thereby crowding out normal cells in the bone marrow preventing normal cells from performing their important functions. According to research citings provided by Bristol-Myers Squibb Company by 2040, approximately 1,100,000 people will die from blood cancer, representing 7 percent deaths from cancer. Allogeneic bone marrow transplant are reigning the market. The inherent features associated with allogeneic procedures are the graft is free from contaminated tumor cells. Immune graft versus malignancy effect is produced by immunocompetent cells derived from healthy donors. Low risk of recurrence of disease and significant increase in the number of healthy donors drive the growth of the market for allogeneic bone marrow transplantation.

Don't miss out on business opportunities in [ Bone Marrow Transplantation Market 2018-2026 ]

In the near future, Autologous procedure will grow at a rapid pace due to rise in number of stem cell banks, which store healthy cells from patients and after conditioning treatment are introduced in them to produce healthy blood cells.
Lymphoma is dominating the indication segment for bone marrow transplantation market. There are 2 types Hodgkin lymphoma and Non-Hodgkin lymphoma. The primary factors responsible for its supremacy are significant rise in the patients newly diagnosed with Hodgkin lymphoma and excellent survival rate in patients post bone marrow transplantation procedure. Leukemia is the abnormal high production of white blood cells by the bone marrow. Technological advancement in the bone marrow transplantation technique will reduce the disease recurrence in leukemia patients receiving stem cell therapy.

North America is currently the leading regional bone marrow transplant market with a market share of 38 percent. The major factors responsible for its significant growth are the increasing prevalence of chronic lymphocytic leukemia and the presence of sophisticated healthcare infrastructure. Europe, with a market share of 32 percent, is in second place due to a significant increase in the number of myeloma patients and the home of major players such as PromoCell GmbH, Merck Millipore Corporation and Lonza Group Ltd. Asia Pacific, with a market share of 20 percent, will grow at a faster pace in the near future due to technological advancement in bone marrow transplantation techniques and proactive government policies to curb the mortality rate associated with blood cancer.

Biotechnology firms actively engaged in bone marrow transplantation procedures are
AllCells LLC.,
Conversant Bio.,
Cellular Dynamics International,
Gamida Cell Ltd.,
Hemacare Corporation,
Lonza Group Ltd.,
Merck Millipore Corporation,
Mesoblast Ltd.,
PromoCell GmbH
STEMCELL Technologies.

Key Market Movements:
Significant rise in the number of new cases diagnosed with lymphoma, leukemia and myeloma
Technological advancement in the bone marrow transplantation technique with minimal ratio of disease recurrence
Rampant growth in the number of healthy donors and stem cell banks worldwide

Get Sample @ https://www.credenceresearch.com/sample-request/59660

Table of Content:
Chapter 1. Preface
..............
Chapter 2. Executive Summary
.............
Chapter 3. Bone Marrow Transplantation Market: Dynamics and Future Outlook
.............
Chapter 4. Global Bone Marrow Transplantation Market, by Type
4.1. Overview
4.2. Allogeneic Bone Marrow Transplant
4.3. Autologous Bone Marrow Transplant

Chapter 5. Global Bone Marrow Transplantation Market, by Indication
5.1. Overview
5.2. Leukemia
5.3. Lymphoma
5.4. Myeloma
5.5. Others

Chapter 6. Global Bone Marrow Transplantation Market, by Geography
.................
Chapter 7. Company Profiles
7.1. AllCells LLC
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Conversant Bio
7.3. Cellular Dynamics International
7.4. Gamida Cell Ltd.
7.5. Hemacare Corporation
7.6. Lonza Group Ltd.
7.7. Merck Millipore Corporation
7.8. Mesoblast Ltd
7.9. PromoCell GmbH
7.10. STEMCELL Technologies.
.........................toc continued

Browse the full report Bone Marrow Transplantation Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/bone-marrow-transplantation-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Related Reports by Credence Research:

Hematopoietic Stem Cells Transplantation Market, By Transplant Type (Allogeneic Transplant, Autologous Transplant), By Application (Leukemia, Lymphoproliferative Disorders, Solid Tumors, Non-Malignant Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Transplant Diagnostics Market By Technology (Molecular Assays, Non-molecular Assays), By Transplant Type (Solid Organ Transplantation, Stem Cell Transplantation), By Application (Pre-transplantation Diagnostics, Post-Transplantation Diagnostics, Research), By Product (Instruments, Reagents And Consumables, Software), By Usage Area (Hospitals And Transplant Centers, Research And Academia, Pathophysiology Laboratories) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Multiple Myeloma Treatment Market, By Type (Drug Therapy, Stem Cell Transplantation, Biophosphonates, Radiation Therapy, & Surgical Therapy) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Related Reports on Acute Market Reports:

Global Bone Marrow Aspirate Concentrates Market Insights, Forecast to 2025

Global Transplantation Diagnostics Market Professional Survey Report 2018

Global Corneal Transplantation Surgical Instrument Package Market Research Report 2017

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Release ID: 502156